Clinical outcomes and hemorrhagic or thromboembolic risks in decompressive craniectomy for patients taking antiplatelet or anticoagulant therapy

被引:0
作者
Alba Scerrati [1 ]
Giovanni Scanferla [2 ]
Lorenzo Sgarbanti [1 ]
Giorgio Mantovani [1 ]
Chiara Angelini [1 ]
Maria Elena Flacco [1 ]
Rosario Maugeri [3 ]
Lapo Bonosi [4 ]
Domenico Gerardo Iacopino [4 ]
Silvana Tumbiolo [4 ]
Alessandro Adorno [5 ]
Lara Brunasso [5 ]
Giorgio Lofrese [5 ]
Vittoria Rosetti [6 ]
Luigino Tosatto [6 ]
Teresa Somma [6 ]
Luigi Maria Cavallo [7 ]
Sara Lombardi [7 ]
Carmelo Lucio Sturiale [7 ]
Francesco Signorelli [8 ]
Anna Maria Auricchio [8 ]
Grazia Menna [8 ]
Luca Ricciardi [8 ]
Nicola Montemurro [9 ]
Fabio Raneri [10 ]
Oriela Rustemi [11 ]
Giampaolo Zambon [11 ]
Michele Alessandro Cavallo [11 ]
Pasquale De Bonis [1 ]
机构
[1] Department of Translational Medicine, University of Ferrara, Ferrara
[2] Department of Neurosurgery, Sant’Anna University Hospital of Ferrara, Ferrara
[3] Environmental and Preventive Sciences, University of Ferrara, Ferrara
[4] Unit of Neurosurgery, AOUP “Paolo Giaccone”, Department of Biomedicine Neurosciences and Advanced Diagnostic (BiND), University of Palermo, Palermo
[5] Unit of Neurosurgery Hospital “Villa Sofia”, Palermo
[6] Neurosurgery Unit, Bufalini Hospital, Cesena
[7] Department of Neurosciences and Reproductive and Dental Sciences, Division of Neurosurgery, Federico II University of Naples, Naples
[8] Department of Neurosurgery, Institute of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, L.Go A. Gemelli 8, Rome
[9] Neurosurgical Unit, Department of Neuroscience, Mental Health, and Sensory Organs, Sapienza University of Rome, Rome
[10] Department of Neurosurgery, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa
[11] Department of Neurosurgery, ULSS8 Berica, Vicenza
关键词
Anticoagulant; Antiplatelet; CHA₂DS₂-VASc; Decompressive craniectomy; Hemorrhagic complications; Thromboembolic complications;
D O I
10.1007/s10143-025-03491-4
中图分类号
学科分类号
摘要
Decompressive craniectomy (DC) is a critical surgical intervention for elevated intracranial pressure. However, the impact of preoperative antiplatelet or anticoagulant therapy on outcomes and complications remains unclear. A retrospective-prospective study was conducted on 145 patients undergoing DC between November 2021 and May 2023. Patients were categorized into two groups: those with (n = 48) and without (n = 97) preoperative antithrombotic therapy. Demographic data, comorbidities, antithrombotic therapy type and duration, clinical outcomes, and pre-operative risk factors (CHA2DS2-VASc and HAS-BLED scores) were analyzed. While there was a trend towards higher hemorrhagic complications in the antithrombotic therapy group (20.0% vs. 11.3%), this difference was not statistically significant. However, thromboembolic events, primarily stroke (27.7% vs. 9.3%) and acute myocardial infarction (10.6% vs. 0.0%), were significantly more frequent in the antithrombotic therapy group. Multivariate analysis revealed that ischemic stroke as a primary diagnosis, rather than antithrombotic therapy itself, was a significant predictor of thromboembolic complications (adjusted OR 3.49, 95%CI 1.47–8.28, p = 0.005). Pre-operative GCS was associated with improved outcomes (adjusted OR 0.81, 95%CI 0.67–0.97, p = 0.025). While antithrombotic therapy does not appear to increase the risk of hemorrhagic complications after DC, it is associated with a higher risk of thromboembolic events, especially in patients with ischemic stroke. Individualized assessment and tailored management of antithrombotic therapy are crucial to optimize outcomes in DC patients. Further studies are needed to refine strategies for bridging anticoagulation and managing antithrombotic therapy in this population, considering factors such as CHA2DS2-VASc and HAS-BLED scores, as well as patient-specific risk profiles. © The Author(s) 2025.
引用
收藏
相关论文
共 18 条
  • [1] Trevisi G., Scerrati A., Rustemi O., Et al., Does the timing of the surgery have a major role in influencing the outcome in elders with acute subdural hematomas?, J Pers Med, 12, 10, (2022)
  • [2] Trevisi G., Sturiale C.L., Scerrati A., Et al., Acute subdural hematoma in the elderly: outcome analysis in a retrospective multicentric series of 213 patients, Neurosurg Focus, 49, 4, (2020)
  • [3] Sturiale C.L., De Bonis P., Rigante L., Et al., Do Traumatic brain contusions increase in size after decompressive craniectomy?, J Neurotrauma, 29, 18, pp. 2723-2726, (2012)
  • [4] Trevisi G., Caccavella V.M., Scerrati A., Et al., Machine learning model prediction of 6-month functional outcome in elderly patients with intracerebral hemorrhage, Neurosurg Rev, 45, 4, pp. 2857-2867, (2022)
  • [5] Angelini C., Zangrossi P., Mantovani G., Cavallo M.A., De Bonis P., Scerrati A., The effect of antiplatelet and anticoagulant therapies on clinical outcome of patients undergoing decompressive craniectomy: a systematic review, Front Neurol, 15, (2024)
  • [6] Kurland D.B., Khaladj-Ghom A., Stokum J.A., Et al., Complications associated with decompressive craniectomy: a systematic review, Neurocrit Care, 23, 2, pp. 292-304, (2015)
  • [7] Han H., Koh E.J., Choi H., Kim B.C., Yang S.Y., Cho K.T., The effect of preoperative antiplatelet therapy on hemorrhagic complications after decompressive craniectomy in patients with traumatic brain injury, Korean J Neurotrauma, 12, 2, pp. 61-66, (2016)
  • [8] Schuss P., Borger V., Vatter H., Singer O.C., Seifert V., Guresir E., Antiplatelet therapy, but not intravenous thrombolytic therapy, is associated with postoperative bleeding complications after decompressive craniectomy for stroke, J Neurol, 260, 8, pp. 2149-2155, (2013)
  • [9] Prior A., Fiaschi P., Iaccarino C., Et al., How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH), BMC Neurol, 21, 1, (2021)
  • [10] Fiaschi P., Iaccarino C., Stefini R., Prior E., Prior A., Zona G., Clinical practice for antiplatelet and anticoagulant therapy in neurosurgery: data from an Italian survey and summary of current recommendations – part I, antiplatelet therapy, Neurosurg Rev, 44, 1, pp. 485-493, (2021)